期刊文献+

掌叶半夏提取物的有效部位对宫颈癌细胞株HPVE6和P53基因表达的影响 被引量:12

Effects of Pinellia extract fraction on expressions of HPVE6 and P53 genes in cervical cancer cell lines
原文传递
导出
摘要 目的:观察中药掌叶半夏提取物的有效部位(PE)对CaSki和HeLa细胞人乳头瘤病毒(HPV)E6基因和P53基因表达的影响,进一步阐明PE的抑癌机制。方法:0.15mg/mL的PE作用于CaSki和HeLa细胞24h后,采用RT-PCR方法检测两种细胞HPVE6和P53 mRNA表达的变化,采用Western Blot检测CaSki和HeLa细胞HPVE6、P53蛋白表达的变化。结果:0.15mg/mL的PE作用24h后CaSki和HeLa细胞HPVE6 mRNA和蛋白的表达均明显下降,而P53mRNA和蛋白的表达均明显上升(P<0.05,P<0.01)。结论:PE可以明显抑制CaSki和HeLa宫颈癌细胞株HPVE6基因的表达、促进其P53基因的表达,这可能是PE抗宫颈癌作用的关键环节。 Objective: To investigate the mechanisms of inhibition effect of Pinellia extract fraction(PE) on CaSki and HeLa cervical cancer cell lines cultured in vitro,observe the effects of PE on expressions of human papilloma viruse(HPV)E6 and P53 in these two kinds of cells.Methods: Expressions of HPVE6 and P53 mRNA were detected by RT-PCR,and expressions of HPVE6 and P53 proteins were detected by western blot assay.Results: Expressions of HPVE6 mRNA and protein were down-regulated,while expressions of P53 mRNA and protein were up-regulated significantly after treatment with 0.15mg/mL PE for 24 hours.Conclusion: PE can inhibit growth of CaSki and HeLa cells by down-regulating expression of HPVE6 and up-regulating expression of P53.This may be the key point of the anti-cervical cancer effect of PE.
出处 《中华中医药杂志》 CAS CSCD 北大核心 2012年第1期110-113,共4页 China Journal of Traditional Chinese Medicine and Pharmacy
基金 上海市自然基金(No.09ZR1404800)~~
关键词 掌叶半夏提取物的有效部位 宫颈癌 CaSki细胞株 HELA细胞株 人乳头瘤病毒E6 P53 Pinellia extract fraction Cervical cancer CaSki cell line HeLa cell line Human papilloma viruse(HPVE6) P53
  • 相关文献

参考文献14

  • 1Munoz N.Human papillomavirus and cancer:the epidemiological evidence.Journal of Clinical Virology,2000,19:1-5.
  • 2Hwang T S,Jeong J K,Park M,et al.Detection and typing of HPV genotypes in various cervical lesions by HPV ollgonucleotlde microarray.Gyneol 0ncol,2003,90(1):51-56.
  • 3Steben M,Franco E D.Human papillomavirus infection: Epidemiology and pathophysiology.Gynecol Onco1.,2007(107): s2-s5.
  • 4Bulk S,Berkhof J,Bulkmans N W,et al.Preferential risk of HPV16 for aquamous cell carcinoma and HPV18 for adenocm~inom of the cervix compared to women with normal cytology in the Netherlans. Br J Cancer,2006,94(1):171-175.
  • 5Parenti A R,Rugge M,Frizzera E,et al.P53 overexpression in the multistep process of esophageal carcinogenesis.Am J Sttrg Pathol, 1995,19:1418-1422.
  • 6Bennett W P,Hollstein M C,Metcalf R A,et a1.P53 mutation and protein accumulation during multistage human esophageal carcinogenesis.Cancer Res,1992,52:6092-6097.
  • 7Scheffner M,Huibregtse J M,Vierstra R D,et al.The HPV-16 E6 and E6-AP complex functions as an ubiquitin-protein ligase in the ubiquitination of P53.Cell, 1993,75:495-505.
  • 8上海第一医学院妇产科医院 基础部化学教研组.掌叶半夏治疗子宫颈癌的研究[J].上海医学,1978,1:13-16.
  • 9上海第一医学院妇产科医院药剂科 基础部化学教研组.谷甾醇栓剂的研制[J].药学通报,1980,15(2):23-26.
  • 10李超荆 徐亚铭 等.掌叶半夏抗子宫颈癌成分的研究[J].上海第一医学院学报,1981,8(6):421-423.

二级参考文献21

  • 1潘启超.新抗癌药——紫杉醇的药理及临床疗效[J].癌症,1994,13(6):553-557. 被引量:16
  • 2王滨,牛欣,韩旭华.中西医结合药理学研究方法探讨[J].中华中医药杂志,2005,20(6):356-358. 被引量:5
  • 3岳凤先,梁慧.中药药理研究与西药药理研究的界定[J].中国中医药信息杂志,1995,2(2):11-12. 被引量:1
  • 4于向东,胡天真.中药复方药理研究思路亟需调整[J].山东中医学院学报,1996,20(3):161-164. 被引量:9
  • 5李超荆 徐亚铭 等.掌叶半夏抗子宫颈癌成分的研究[J].上海第一医学院学报,1981,8(6):421-423.
  • 6Munoz N.Human papillomavirus and cancer: the epidemiological evidence. Journal of Clinical Virology,2000,19:1-5.
  • 7Hwang T S,Jeong J K, Park M, et al. Detection and typing of HPV genotypes in various cervical lesions by HPV oligonucleotide microarray.Gyneol Oncol,2003,90(1):51-56.
  • 8Chetmg T H,Chung T K, Lo K W, et al.Apoptosis related proteins in cervical intraepithelial neoplasia and squamous cell carcinoma of the cervix.Gynecol Oncol,2002,86( 1 ): 14-18.
  • 9上海第一医学院妇产科医院 基础部化学教研组.掌叶半夏治疗子宫颈癌的研究[J].上海医学,1978,1:13-16.
  • 10Hino N, Higashi T, Nouso K. Apoptosis and proliferation of human hepatocellular carcinoma. Liver, 1996, 16:123 ~129

共引文献34

同被引文献293

引证文献12

二级引证文献144

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部